Pancreatic Cancer Research

ResearcherKurume UniversityActive in the last 2 years

Takahiko Sakaue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-1814-3456; OpenAlex author ID A5110645385. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers

Papers 4

  1. Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.gastha.2024.04.011↗
  2. Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication. Co-author DOI 10.1111/hepr.14081↗
  3. A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer. Co-author DOI 10.1097/md.0000000000026052↗
  4. Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer. Co-author DOI 10.1007/s00795-019-00218-5↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takumi Kawaguchi · 2 shared papers, 2024 · strength 0.48
  2. Yoshinobu Okabe · 3 shared papers, 2019–2024 · strength 0.37
  3. Takuji Torimura · 3 shared papers, 2019–2024 · strength 0.37
  4. Yoshiki Naito · 2 shared papers, 2021–2024 · strength 0.29
  5. Hironori Koga · 2 shared papers, 2019–2024 · strength 0.25
  6. Tomoyuki Ushijima · 2 shared papers, 2019–2021 · strength 0.20
  7. Masaru Fukahori · 2 shared papers, 2019–2021 · strength 0.20
  8. Toru Hisaka · 1 shared paper, 2024 · strength 0.17
  9. Tõru Nakamura · 1 shared paper, 2024 · strength 0.17
  10. Keisuke Miwa · 1 shared paper, 2021 · strength 0.12
  11. Toru Nakamura · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.